| A. Bourla | Chairman and Chief Executive Officer | FY2024 | |
| A. Malik | Chief U.S. Commercial Officer, EVP | FY2025 | |
| D. Denton | Chief Financial Officer, EVP | FY2024 | |
| C. Boshoff | Chief Scientific Officer and President, Research & Development | FY2024 | |
| D. Lankler | General Counsel, EVP | FY2024 | |
| Albert Bourla, DVM, Ph.D. | Director | Not disclosed | — |
6 executives
Named executives and their total pay come from the Summary Compensation Table of the latest proxy statement.